[go: up one dir, main page]

AR002041A1 - Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides. - Google Patents

Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.

Info

Publication number
AR002041A1
AR002041A1 ARP960102178A AR10217896A AR002041A1 AR 002041 A1 AR002041 A1 AR 002041A1 AR P960102178 A ARP960102178 A AR P960102178A AR 10217896 A AR10217896 A AR 10217896A AR 002041 A1 AR002041 A1 AR 002041A1
Authority
AR
Argentina
Prior art keywords
procedure
radical
preparing
taxoids
general formula
Prior art date
Application number
ARP960102178A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of AR002041A1 publication Critical patent/AR002041A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nuevos taxoides de la fórmula general (I); su preparación, y las composiciones farmacéuticas que los contienen. En la fórmula general (I) Zrepresenta un átomo de hidrógeno o un radical de la fórmula general (II) en la cual: R1 representaun radical benzoilo eventualmente o un radical R2-O-CO- enel cual R2 representa un radical alcoílo, alcenilo, alcinilo, cicloalcoílo, cicloalcenilo,bicicloalcoílo, fenilo eventualmente sustituido o heterocíclico;R3 representa un radical alcoílo,, alcenilo, alcinilo, cicloalcoílo, fenilo, naftilo o heterocíclico aromático,R4 representa un radical alcoxi, alceniloxi,alciniloxi, cicloalcoíloxi o cicloalceniloxi eventualmente sustituido. Los novedosos productos de fórmula general (I) en la cual Z representa un radicalde fórmula general (II) presentan notables propiedades anti-tumorales y antileucémicas.
ARP960102178A 1995-04-14 1996-04-12 Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides. AR002041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9504559A FR2732968B1 (fr) 1995-04-14 1995-04-14 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR002041A1 true AR002041A1 (es) 1998-01-07

Family

ID=9478163

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102178A AR002041A1 (es) 1995-04-14 1996-04-12 Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.

Country Status (16)

Country Link
US (1) US5906990A (es)
EP (1) EP0820448B1 (es)
JP (1) JP4308905B2 (es)
AR (1) AR002041A1 (es)
AT (1) ATE193533T1 (es)
AU (1) AU5652296A (es)
DE (1) DE69608680T2 (es)
DK (1) DK0820448T3 (es)
ES (1) ES2148758T3 (es)
FR (1) FR2732968B1 (es)
GR (1) GR3033591T3 (es)
IL (1) IL117878A (es)
PT (1) PT820448E (es)
TW (1) TW349095B (es)
WO (1) WO1996032387A1 (es)
ZA (1) ZA962900B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136961A (en) * 1995-09-11 2000-10-24 Enzymed, Inc. Biocatalytic methods for synthesizing and identifying biologically active compounds
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
KR20010079665A (ko) * 1998-08-20 2001-08-22 추후제출 탁소이드 유도체의 신규 용도
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives
CA2365776A1 (en) * 1999-05-03 2000-11-09 Alain Renard Method for treating abnormal cell proliferation in the brain
CZ20013520A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. C10 - Karbamoyloxy substituované taxany jako protinádorová činidla
CZ20013405A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. C10 karbonátem substituované taxany jako protinádorová činidla
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
WO2002066448A1 (en) * 2001-02-20 2002-08-29 Dabur India Limited Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
FR2853651B1 (fr) * 2003-04-14 2005-05-20 Aventis Pharma Sa Procede de preparation du 4,10 beta-diacetoxy-2 alpha- benzoyloxy-5 beta, 20-epoxy-1, 13 alpha-dihydroxy-9-oxo-19- norcyclopropa[g]tax-11-ene
US6956124B2 (en) 2003-04-14 2005-10-18 Aventis Pharma S.A. Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene
US20080107721A1 (en) * 2003-05-20 2008-05-08 Jonathan Lewis Combination Chemotherapy Comprising A Liposomal Platinum Complex
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
HN2005000054A (es) * 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
WO2006088767A2 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
US20090076127A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched larotaxel
US8242166B2 (en) * 2008-03-31 2012-08-14 Florida State University Research Foundation, Inc. C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
EP2177630A1 (en) * 2008-10-02 2010-04-21 Institut Gustave Roussy Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2710642B1 (fr) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5395850A (en) * 1994-03-10 1995-03-07 Bristol-Myers Squibb Company 6,7-epoxy paclitaxels
FR2718135B1 (fr) * 1994-04-05 1996-04-26 Rhone Poulenc Rorer Sa Procédé de préparation d'hydroxy-7 taxanes.

Also Published As

Publication number Publication date
GR3033591T3 (en) 2000-09-29
DE69608680D1 (de) 2000-07-06
FR2732968B1 (fr) 1997-05-16
ES2148758T3 (es) 2000-10-16
PT820448E (pt) 2000-09-29
FR2732968A1 (fr) 1996-10-18
DE69608680T2 (de) 2000-10-19
AU5652296A (en) 1996-10-30
JP4308905B2 (ja) 2009-08-05
WO1996032387A1 (fr) 1996-10-17
JPH11503443A (ja) 1999-03-26
TW349095B (en) 1999-01-01
ZA962900B (en) 1996-07-30
DK0820448T3 (da) 2000-08-21
EP0820448B1 (fr) 2000-05-31
EP0820448A1 (fr) 1998-01-28
IL117878A (en) 2001-03-19
ATE193533T1 (de) 2000-06-15
IL117878A0 (en) 1996-08-04
US5906990A (en) 1999-05-25

Similar Documents

Publication Publication Date Title
AR002041A1 (es) Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.
MX9307748A (es) Nuevo taxoides, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2140075T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
BG92804A (bg) 4-бензоилизоксазолови производни
MX9303770A (es) Derivados de alquilamino ramificados de tiazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2101513T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MY103233A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ES2151155T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
NO912629L (no) Fremgangsmaate for fremstilling av nye bis(4-(2,6-dialkyl)fenol)silanderivater som antiarteriosklerotiske midler
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
ES2131864T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
UY23088A1 (es) Procedimiento para la preparacion de derivados de n-fenilpirazol
ES2079982T3 (es) Procedimiento para la preparacion de derivados del taxano.
ES2121395T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
AR004406A1 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen.
FI904663A0 (fi) Nya substituerade alkylpiperidiner och deras anvaendning som inhibitorer i kolesterolsyntes.
AR032373A2 (es) Intermediarios para preparar 3-(1-piperazinil)-1,2-benzoisotiazol.